Hematopoietic stem cell transplantation for primary immunodeficiencies

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• Primary immunodeficiencies (PIDs) are a group of rare genetic disorders affecting the immune system.
• Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many PIDs.
• Standardized HSCT regimens are challenging due to the heterogeneity of PIDs.

Purpose of the Study:

• To review primary immunodeficiencies most frequently treated with HSCT.
• To outline the specific challenges and considerations for HSCT in these PIDs.

Main Methods:

• Literature review of PIDs treated with HSCT.
• Analysis of transplant protocols and outcomes for specific immunodeficiencies.

Main Results:

• Identified common PIDs amenable to HSCT, including severe combined immunodeficiency (SCID) and chronic granulomatous disease (CGD).
• Highlighted variations in conditioning regimens, stem cell sources, and post-transplant management based on PID type.
• Discussed specific complications such as graft-versus-host disease (GVHD) and infections.

Conclusions:

• HSCT is a vital therapeutic option for severe primary immunodeficiencies.
• Tailoring HSCT regimens to the specific pathophysiology of each PID is crucial for successful outcomes.
• Further research is needed to optimize HSCT protocols for rare and complex immunodeficiencies.